Antiplatelet therapy in endovascular surgery: The RENDOVASC study

Annals of Vascular Surgery

Volumn 27, Issue 2, 2013, Pages 168-177

  Matas, Manuel ^a   Domínguez González, José Manuel ^a   Montull, Eugeni ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Centro de Investigation Basica Sanofi Aventis   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANGIOPLASTY; ANTICOAGULANT THERAPY; ARTERY DISEASE; ARTERY OCCLUSION; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COMBINATION CHEMOTHERAPY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; ENDOPROSTHESIS; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; ILIAC ARTERY; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONOTHERAPY; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; PERIOPERATIVE PERIOD; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPAIN; STENT; SURGICAL PATIENT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSEL PROSTHESIS IMPLANTATION; CONSENSUS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ENDOVASCULAR PROCEDURES; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPAIN; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR DISEASES; YOUNG ADULT;

EID: 84873367240     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2011.11.045     Document Type: Article

References (24)

1. M. Sobel, and R. Verhaeghe Antithrombotic therapy for peripheral arterial occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 Suppl 2008 815S 843S
2. P. Poredos, and M.K. Jezovnik Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease Int Angiol 29 2010 20 26
3. L. Norgren, W.R. Hiatt, and J.A. Dormandy TransAtlantic Intersociety Consensus for Management of Peripheral Arterial Disease TASC II Eur J Vasc Endovasc Surg 33 Suppl 1) 2007 S1 S75
4. K.T. Reaume, R.E. Regal, and M.P. Dorsch Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use Ann Pharmacother 42 2008 550 557
5. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
6. D.L. Bhatt, and E.J. Topol Clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance executive committee. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA) trial Am Heart J 148 2004 263 268
7. P. Hall, S. Nakamura, and L. Maiello A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation Circulation 93 1996 215 222
8. P.B. Berger Results of the ticlid or plavix post-stents (TOPPS) trial: do they justify the switch from ticlopidine to clopidogrel after coronary stent placement? Curr Control Trials Cardiovasc Med 1 2000 83 87
9. J. Dörffler-Melly, M.M. Koopman, M.H. Prins, and H.R. Büller Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment Cochrane Database Syst Rev 1 2005 CD002071
10. W.R. Hiatt Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy J Intern Med 251 2002 193 206
11. A.B. Newman, D.S. Siscovick, and T.A. Manolio Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study Circulation 88 1993 837 845
12. CAPRIE Steering Committee A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
13. Antithrombotic trialist's Collaboration Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients BMJ 324 2002 71 86
14. J. Brown, A. Lethaby, H. Maxwell, A.J. Wawrzyniak, and M.H. Prins Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery Cochrane Database Syst Rev 4 2008 CD000535
15. A. Mongiardo, A. Curcio, C. Spaccarotella, S. Parise, and C. Indolfi Molecular mechanisms of restenosis after percutaneous peripheral angioplasty and approach to endovascular therapy Curr Drug Targets Cardiovasc Haemat Dis 4 2004 275 287
16. R.S. Schwartz Pathophysiology of restenosis: interaction of thrombosis, hyperplasia and/or remodeling Am J Cardiol 81 1998 14E 17E
17. A. Visona, D. Tonello, and B. Zalunardo Antithrombotic treatment before and after peripheral artery percutaneous angioplasty Blood Transfus 7 2009 18 23
18. M. Schillinger, M. Exner, and W. Mlekusch Inflammatory response to stent implantation: differences in femoro-popliteal, iliac and carotid arteries Radiology 2 2002 529 535
19. K. Cassar, I. Ford, M. Greaves, Bachoo, and J. Brittenden Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty Br J Surg 92 2005 159 165
20. A.M. Wilson, J. Brittenden, P. Bachoo, I. Ford, and G.F. Nixon Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty J Vasc Surg 50 2009 861 869
21. E.P.K. Strecker, I.B.L. Boos, D. Göttmann, and S. Vetter Clopidogrel plus long-term aspirin after femoro-popliteal stenting. The CLAFS project: 1 and 2 years results Eur Radiol 14 2004 302 308
22. E. Minar, A. Ahmadi, and R. Koppensteiner Comparison of effects of high-dose and low-dose aspirin on restenosis after femoro-popliteal percutaneous transluminal angioplasty Circulation 91 1995 2167 2173
23. S.R. Mehta, S. Yusuf, and R.J. Peters Clopidogrel in unstable angina to prevent recurrent events trial (CURE) investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
24. I. Dalainas, G. Nano, P. Bianchi, S. Stegher, G. Malacrida, and D.G. Tealdi Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting Cardiovasc Intervent Radiol 29 2006 519 521